digitoxigenin and Leishmaniasis--Visceral

digitoxigenin has been researched along with Leishmaniasis--Visceral* in 1 studies

Other Studies

1 other study(ies) available for digitoxigenin and Leishmaniasis--Visceral

Article	Year
Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis. Parasitology research, 2021, Volume: 120, Issue:1 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Deoxycholic Acid; Digitoxigenin; Drug Combinations; Drug Repositioning; Female; Leishmania infantum; Leishmaniasis, Visceral; Liver; Macrophages; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Micelles; Parasite Load; Poloxamer; Reactive Oxygen Species; Spleen	2021

Article

Year

Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis.

Parasitology research, 2021, Volume: 120, Issue:1

Topics: Amphotericin B; Animals; Antiprotozoal Agents; Deoxycholic Acid; Digitoxigenin; Drug Combinations; Drug Repositioning; Female; Leishmania infantum; Leishmaniasis, Visceral; Liver; Macrophages; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Micelles; Parasite Load; Poloxamer; Reactive Oxygen Species; Spleen

2021